1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Novel Vaccine Delivery Systems Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Intramuscular Delivery
        1.2.3 Intramuscular Delivery
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Novel Vaccine Delivery Systems Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals & Clinics
        1.3.3 Research Institutes
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Novel Vaccine Delivery Systems Market Perspective (2017-2028)
    2.2 Novel Vaccine Delivery Systems Growth Trends by Region
        2.2.1 Novel Vaccine Delivery Systems Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Novel Vaccine Delivery Systems Historic Market Size by Region (2017-2022)
        2.2.3 Novel Vaccine Delivery Systems Forecasted Market Size by Region (2023-2028)
    2.3 Novel Vaccine Delivery Systems Market Dynamics
        2.3.1 Novel Vaccine Delivery Systems Industry Trends
        2.3.2 Novel Vaccine Delivery Systems Market Drivers
        2.3.3 Novel Vaccine Delivery Systems Market Challenges
        2.3.4 Novel Vaccine Delivery Systems Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Novel Vaccine Delivery Systems Players by Revenue
        3.1.1 Global Top Novel Vaccine Delivery Systems Players by Revenue (2017-2022)
        3.1.2 Global Novel Vaccine Delivery Systems Revenue Market Share by Players (2017-2022)
    3.2 Global Novel Vaccine Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Novel Vaccine Delivery Systems Revenue
    3.4 Global Novel Vaccine Delivery Systems Market Concentration Ratio
        3.4.1 Global Novel Vaccine Delivery Systems Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Novel Vaccine Delivery Systems Revenue in 2021
    3.5 Novel Vaccine Delivery Systems Key Players Head office and Area Served
    3.6 Key Players Novel Vaccine Delivery Systems Product Solution and Service
    3.7 Date of Enter into Novel Vaccine Delivery Systems Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Novel Vaccine Delivery Systems Breakdown Data by Type
    4.1 Global Novel Vaccine Delivery Systems Historic Market Size by Type (2017-2022)
    4.2 Global Novel Vaccine Delivery Systems Forecasted Market Size by Type (2023-2028)
5 Novel Vaccine Delivery Systems Breakdown Data by Application
    5.1 Global Novel Vaccine Delivery Systems Historic Market Size by Application (2017-2022)
    5.2 Global Novel Vaccine Delivery Systems Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Novel Vaccine Delivery Systems Market Size (2017-2028)
    6.2 North America Novel Vaccine Delivery Systems Market Size by Country (2017-2022)
    6.3 North America Novel Vaccine Delivery Systems Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Novel Vaccine Delivery Systems Market Size (2017-2028)
    7.2 Europe Novel Vaccine Delivery Systems Market Size by Country (2017-2022)
    7.3 Europe Novel Vaccine Delivery Systems Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Novel Vaccine Delivery Systems Market Size (2017-2028)
    8.2 Asia-Pacific Novel Vaccine Delivery Systems Market Size by Country (2017-2022)
    8.3 Asia-Pacific Novel Vaccine Delivery Systems Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Novel Vaccine Delivery Systems Market Size (2017-2028)
    9.2 Latin America Novel Vaccine Delivery Systems Market Size by Country (2017-2022)
    9.3 Latin America Novel Vaccine Delivery Systems Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Novel Vaccine Delivery Systems Market Size (2017-2028)
    10.2 Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2017-2022)
    10.3 Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Altaris Capital Partners
        11.1.1 Altaris Capital Partners Company Detail
        11.1.2 Altaris Capital Partners Business Overview
        11.1.3 Altaris Capital Partners Novel Vaccine Delivery Systems Introduction
        11.1.4 Altaris Capital Partners Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
        11.1.5 Altaris Capital Partners Recent Development
    11.2 Kindeva Drug Delivery
        11.2.1 Kindeva Drug Delivery Company Detail
        11.2.2 Kindeva Drug Delivery Business Overview
        11.2.3 Kindeva Drug Delivery Novel Vaccine Delivery Systems Introduction
        11.2.4 Kindeva Drug Delivery Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
        11.2.5 Kindeva Drug Delivery Recent Development
    11.3 Becton
        11.3.1 Becton Company Detail
        11.3.2 Becton Business Overview
        11.3.3 Becton Novel Vaccine Delivery Systems Introduction
        11.3.4 Becton Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
        11.3.5 Becton Recent Development
    11.4 Dickinson,
        11.4.1 Dickinson, Company Detail
        11.4.2 Dickinson, Business Overview
        11.4.3 Dickinson, Novel Vaccine Delivery Systems Introduction
        11.4.4 Dickinson, Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
        11.4.5 Dickinson, Recent Development
    11.5 Carl Zeiss Foundation
        11.5.1 Carl Zeiss Foundation Company Detail
        11.5.2 Carl Zeiss Foundation Business Overview
        11.5.3 Carl Zeiss Foundation Novel Vaccine Delivery Systems Introduction
        11.5.4 Carl Zeiss Foundation Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
        11.5.5 Carl Zeiss Foundation Recent Development
    11.6 Gerresheimer AG
        11.6.1 Gerresheimer AG Company Detail
        11.6.2 Gerresheimer AG Business Overview
        11.6.3 Gerresheimer AG Novel Vaccine Delivery Systems Introduction
        11.6.4 Gerresheimer AG Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
        11.6.5 Gerresheimer AG Recent Development
    11.7 Corium International
        11.7.1 Corium International Company Detail
        11.7.2 Corium International Business Overview
        11.7.3 Corium International Novel Vaccine Delivery Systems Introduction
        11.7.4 Corium International Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
        11.7.5 Corium International Recent Development
    11.8 Inovio Pharmaceuticals
        11.8.1 Inovio Pharmaceuticals Company Detail
        11.8.2 Inovio Pharmaceuticals Business Overview
        11.8.3 Inovio Pharmaceuticals Novel Vaccine Delivery Systems Introduction
        11.8.4 Inovio Pharmaceuticals Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
        11.8.5 Inovio Pharmaceuticals Recent Development
    11.9 Bioject Medical Technologies
        11.9.1 Bioject Medical Technologies Company Detail
        11.9.2 Bioject Medical Technologies Business Overview
        11.9.3 Bioject Medical Technologies Novel Vaccine Delivery Systems Introduction
        11.9.4 Bioject Medical Technologies Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
        11.9.5 Bioject Medical Technologies Recent Development
    11.10 PharmaJet
        11.10.1 PharmaJet Company Detail
        11.10.2 PharmaJet Business Overview
        11.10.3 PharmaJet Novel Vaccine Delivery Systems Introduction
        11.10.4 PharmaJet Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
        11.10.5 PharmaJet Recent Development
    11.11 Retractable Technologies
        11.11.1 Retractable Technologies Company Detail
        11.11.2 Retractable Technologies Business Overview
        11.11.3 Retractable Technologies Novel Vaccine Delivery Systems Introduction
        11.11.4 Retractable Technologies Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
        11.11.5 Retractable Technologies Recent Development
    11.12 Terumo Corporation
        11.12.1 Terumo Corporation Company Detail
        11.12.2 Terumo Corporation Business Overview
        11.12.3 Terumo Corporation Novel Vaccine Delivery Systems Introduction
        11.12.4 Terumo Corporation Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
        11.12.5 Terumo Corporation Recent Development
    11.13 VAXXAS
        11.13.1 VAXXAS Company Detail
        11.13.2 VAXXAS Business Overview
        11.13.3 VAXXAS Novel Vaccine Delivery Systems Introduction
        11.13.4 VAXXAS Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
        11.13.5 VAXXAS Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
                  
              

                

                 
List of Tables
    Table 1. Global Novel Vaccine Delivery Systems Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Intramuscular Delivery
    Table 3. Key Players of Intramuscular Delivery
    Table 4. Key Players of Others
    Table 5. Global Novel Vaccine Delivery Systems Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Novel Vaccine Delivery Systems Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Novel Vaccine Delivery Systems Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Novel Vaccine Delivery Systems Market Share by Region (2017-2022)
    Table 9. Global Novel Vaccine Delivery Systems Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Novel Vaccine Delivery Systems Market Share by Region (2023-2028)
    Table 11. Novel Vaccine Delivery Systems Market Trends
    Table 12. Novel Vaccine Delivery Systems Market Drivers
    Table 13. Novel Vaccine Delivery Systems Market Challenges
    Table 14. Novel Vaccine Delivery Systems Market Restraints
    Table 15. Global Novel Vaccine Delivery Systems Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Novel Vaccine Delivery Systems Market Share by Players (2017-2022)
    Table 17. Global Top Novel Vaccine Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Vaccine Delivery Systems as of 2021)
    Table 18. Ranking of Global Top Novel Vaccine Delivery Systems Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Novel Vaccine Delivery Systems Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Novel Vaccine Delivery Systems Product Solution and Service
    Table 22. Date of Enter into Novel Vaccine Delivery Systems Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Novel Vaccine Delivery Systems Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Novel Vaccine Delivery Systems Revenue Market Share by Type (2017-2022)
    Table 26. Global Novel Vaccine Delivery Systems Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Novel Vaccine Delivery Systems Revenue Market Share by Type (2023-2028)
    Table 28. Global Novel Vaccine Delivery Systems Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Novel Vaccine Delivery Systems Revenue Market Share by Application (2017-2022)
    Table 30. Global Novel Vaccine Delivery Systems Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Novel Vaccine Delivery Systems Revenue Market Share by Application (2023-2028)
    Table 32. North America Novel Vaccine Delivery Systems Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Novel Vaccine Delivery Systems Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Novel Vaccine Delivery Systems Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Novel Vaccine Delivery Systems Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Novel Vaccine Delivery Systems Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Novel Vaccine Delivery Systems Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Novel Vaccine Delivery Systems Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Novel Vaccine Delivery Systems Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Altaris Capital Partners Company Detail
    Table 43. Altaris Capital Partners Business Overview
    Table 44. Altaris Capital Partners Novel Vaccine Delivery Systems Product
    Table 45. Altaris Capital Partners Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
    Table 46. Altaris Capital Partners Recent Development
    Table 47. Kindeva Drug Delivery Company Detail
    Table 48. Kindeva Drug Delivery Business Overview
    Table 49. Kindeva Drug Delivery Novel Vaccine Delivery Systems Product
    Table 50. Kindeva Drug Delivery Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
    Table 51. Kindeva Drug Delivery Recent Development
    Table 52. Becton Company Detail
    Table 53. Becton Business Overview
    Table 54. Becton Novel Vaccine Delivery Systems Product
    Table 55. Becton Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
    Table 56. Becton Recent Development
    Table 57. Dickinson, Company Detail
    Table 58. Dickinson, Business Overview
    Table 59. Dickinson, Novel Vaccine Delivery Systems Product
    Table 60. Dickinson, Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
    Table 61. Dickinson, Recent Development
    Table 62. Carl Zeiss Foundation Company Detail
    Table 63. Carl Zeiss Foundation Business Overview
    Table 64. Carl Zeiss Foundation Novel Vaccine Delivery Systems Product
    Table 65. Carl Zeiss Foundation Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
    Table 66. Carl Zeiss Foundation Recent Development
    Table 67. Gerresheimer AG Company Detail
    Table 68. Gerresheimer AG Business Overview
    Table 69. Gerresheimer AG Novel Vaccine Delivery Systems Product
    Table 70. Gerresheimer AG Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
    Table 71. Gerresheimer AG Recent Development
    Table 72. Corium International Company Detail
    Table 73. Corium International Business Overview
    Table 74. Corium International Novel Vaccine Delivery Systems Product
    Table 75. Corium International Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
    Table 76. Corium International Recent Development
    Table 77. Inovio Pharmaceuticals Company Detail
    Table 78. Inovio Pharmaceuticals Business Overview
    Table 79. Inovio Pharmaceuticals Novel Vaccine Delivery Systems Product
    Table 80. Inovio Pharmaceuticals Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
    Table 81. Inovio Pharmaceuticals Recent Development
    Table 82. Bioject Medical Technologies Company Detail
    Table 83. Bioject Medical Technologies Business Overview
    Table 84. Bioject Medical Technologies Novel Vaccine Delivery Systems Product
    Table 85. Bioject Medical Technologies Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
    Table 86. Bioject Medical Technologies Recent Development
    Table 87. PharmaJet Company Detail
    Table 88. PharmaJet Business Overview
    Table 89. PharmaJet Novel Vaccine Delivery Systems Product
    Table 90. PharmaJet Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
    Table 91. PharmaJet Recent Development
    Table 92. Retractable Technologies Company Detail
    Table 93. Retractable Technologies Business Overview
    Table 94. Retractable Technologies Novel Vaccine Delivery SystemsProduct
    Table 95. Retractable Technologies Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
    Table 96. Retractable Technologies Recent Development
    Table 97. Terumo Corporation Company Detail
    Table 98. Terumo Corporation Business Overview
    Table 99. Terumo Corporation Novel Vaccine Delivery SystemsProduct
    Table 100. Terumo Corporation Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
    Table 101. Terumo Corporation Recent Development
    Table 102. VAXXAS Company Detail
    Table 103. VAXXAS Business Overview
    Table 104. VAXXAS Novel Vaccine Delivery SystemsProduct
    Table 105. VAXXAS Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
    Table 106. VAXXAS Recent Development
    Table 107. Research Programs/Design for This Report
    Table 108. Key Data Information from Secondary Sources
    Table 109. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Novel Vaccine Delivery Systems Market Share by Type: 2021 VS 2028
    Figure 2. Intramuscular Delivery Features
    Figure 3. Intramuscular Delivery Features
    Figure 4. Others Features
    Figure 5. Global Novel Vaccine Delivery Systems Market Share by Application in 2021 & 2028
    Figure 6. Hospitals & Clinics Case Studies
    Figure 7. Research Institutes Case Studies
    Figure 8. Others Case Studies
    Figure 9. Novel Vaccine Delivery Systems Report Years Considered
    Figure 10. Global Novel Vaccine Delivery Systems Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Novel Vaccine Delivery Systems Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Novel Vaccine Delivery Systems Market Share by Region: 2021 VS 2028
    Figure 13. Global Novel Vaccine Delivery Systems Market Share by Players in 2021
    Figure 14. Global Top Novel Vaccine Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Vaccine Delivery Systems as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Novel Vaccine Delivery Systems Revenue in 2021
    Figure 16. North America Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Novel Vaccine Delivery Systems Market Share by Country (2017-2028)
    Figure 18. United States Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Novel Vaccine Delivery Systems Market Share by Country (2017-2028)
    Figure 22. Germany Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Novel Vaccine Delivery Systems Market Share by Region (2017-2028)
    Figure 30. China Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Novel Vaccine Delivery Systems Market Share by Country (2017-2028)
    Figure 38. Mexico Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Novel Vaccine Delivery Systems Market Share by Country (2017-2028)
    Figure 42. Turkey Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Altaris Capital Partners Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
    Figure 45. Kindeva Drug Delivery Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
    Figure 46. Becton Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
    Figure 47. Dickinson, Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
    Figure 48. Carl Zeiss Foundation Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
    Figure 49. Gerresheimer AG Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
    Figure 50. Corium International Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
    Figure 51. Inovio Pharmaceuticals Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
    Figure 52. Bioject Medical Technologies Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
    Figure 53. PharmaJet Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
    Figure 54. Retractable Technologies Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
    Figure 55. Terumo Corporation Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
    Figure 56. VAXXAS Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed